Nagata Y, Fujino Y, Ono A, Mochizuki M, Mouri H, Oka S, Kimura S, Shimada K
Department of Ophthalmology, University of Tokyo School of Medicine, Japan.
Nippon Ganka Gakkai Zasshi. 1994 Jul;98(7):710-5.
A 41-year-old man with acquired immunodeficiency syndrome (AIDS) developed cytomegalovirus (CMV) retinitis. Intravenous administration of ganciclovir arrested progression of the retinitis, but it was discontinued due to side effects of severe anemia, neutropenia, and thrombocytopenia. Reactivation of CMV retinitis occurred two weeks after stopping ganciclovir, and then forscarnet was given intravenously. The response was prompt with resolution of the retinitis. There was no progression of retinitis during the treatment. The patient experienced renal dysfunction as a side effect of foscarnet, but it was reversible. As with ganciclovir, foscarnet appeared to be an effective drug for CMV retinitis associated with AIDS. Both drugs have severe adverse events: foscarnet causes renal dysfunction and ganciclovir causes myelosuppression, that necessitated discontinuation of the therapy. We suggest that alternating ganciclovir and foscarnet administration, switching to other treatment on the basis of the clinical response and side effects of the drugs, is an efficacious regimen for the treatment of CMV retinitis associated with AIDS.
一名41岁的获得性免疫缺陷综合征(AIDS)患者发生了巨细胞病毒(CMV)视网膜炎。静脉注射更昔洛韦使视网膜炎的进展得到了控制,但由于严重贫血、中性粒细胞减少和血小板减少等副作用而停药。停用更昔洛韦两周后,CMV视网膜炎复发,随后静脉给予膦甲酸钠。治疗反应迅速,视网膜炎消退。治疗期间视网膜炎没有进展。患者出现了膦甲酸钠的副作用——肾功能不全,但这是可逆的。与更昔洛韦一样,膦甲酸钠似乎是治疗与AIDS相关的CMV视网膜炎的有效药物。两种药物都有严重的不良事件:膦甲酸钠导致肾功能不全,更昔洛韦导致骨髓抑制,这使得治疗不得不中断。我们建议,交替使用更昔洛韦和膦甲酸钠,并根据药物的临床反应和副作用切换到其他治疗方法,是治疗与AIDS相关的CMV视网膜炎的有效方案。